Together this work demonstrates that in a mouse model of SMA, over expression of SNCA can impact upon the neurodegenerative pathways, and has the capacity to extend lifespan and ameliorate the phenotype. The gene discussed is SNCA; the disease is proximal spinal muscular atrophy.